Evidence map›Paper›PMID 39080444›Full record

ArticleScientific reports2024

Investigating quantitative histological characteristics in renal pathology using HistoLens.

Samuel P Border, John E Tomaszewski, Teruhiko Yoshida, Jeffrey B Kopp, Jeffrey B Hodgin, William L Clapp, Avi Z Rosenberg, Jill P Buyon, Pinaki Sarder

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Samuel P BorderSection of Quantitative Health, Division of Nephrology, Hypertension, and Renal Transplantation, Department of Medicine, University of Florida, 1600 SW Archer Rd., Gainesville, FL, 32608, USA.
John E TomaszewskiDepartment of Pathology & Anatomical Sciences, University at Buffalo, Buffalo, NY, USA.
Teruhiko YoshidaKidney Disease Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Jeffrey B KoppKidney Disease Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Jeffrey B HodginDepartment of Pathology, University of Michigan, Ann Arbor, MI, USA.
William L ClappDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA.
Avi Z RosenbergDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Jill P BuyonNew York University Grossman School of Medicine, New York, NY, USA.
Pinaki SarderSection of Quantitative Health, Division of Nephrology, Hypertension, and Renal Transplantation, Department of Medicine, University of Florida, 1600 SW Archer Rd., Gainesville, FL, 32608, USA. pinaki.sarder@medicine.ufl.edu.

Funding

YAP1 and RB1 cooperate to regulate lung cancer lineage plasticity and therapeutic resistanceU24CA274159 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI DAVID W. GOODRICH, Alan David Hutson · 2022 to 2026
$8.5M
A Computational IMage Analysis Platform (CIMAP) for HuBMAPOT2OD033753 · OD · UNIVERSITY OF FLORIDA · PI JAIN, SANJAY, SARDER, PINAKI · 2022 to 2025
$4.9M
Computational Imaging of Renal Structures for Diagnosing DiabeticNephropathyR01DK114485 · NIDDK · UNIVERSITY OF FLORIDA · PI Michael Thomas Eadon, Avi Z Rosenberg · 2018 to 2026
$4.7M
A Cloud Based Distributed Tool for Computational Renal PathologyR21DK128668 · NIDDK · UNIVERSITY OF FLORIDA · PI SARDER, PINAKI · 2022 to 2023
$444k
NCI NIH HHS U24 CA274159NIDDK NIH HHS DK ZO1-04330850NIDDK NIH HHS R01 DK114485NIDDK NIH HHS R21 DK128668NIH HHS OT2 OD033753NIH HHS U24 CA274159ODCDC CDC HHS OT2 OD033753
6 · The paper itself

Abstract

HistoLens is an open-source graphical user interface developed using MATLAB AppDesigner for visual and quantitative analysis of histological datasets. HistoLens enables users to interrogate sets of digitally annotated whole slide images to efficiently characterize histological differences between disease and experimental groups. Users can dynamically visualize the distribution of 448 hand-engineered features quantifying color, texture, morphology, and distribution across microanatomic sub-compartments. Additionally, users can map differentially detected image features within the images by highlighting affected regions. We demonstrate the utility of HistoLens to identify hand-engineered features that correlate with pathognomonic renal glomerular characteristics distinguishing diabetic nephropathy and amyloid nephropathy from the histologically unremarkable glomeruli in minimal change disease. Additionally, we examine the use of HistoLens for glomerular feature discovery in the Tg26 mouse model of HIV-associated nephropathy. We identify numerous quantitative glomerular features distinguishing Tg26 transgenic mice from wild-type mice, corresponding to a progressive renal disease phenotype. Thus, we demonstrate an off-the-shelf and ready-to-use toolkit for quantitative renal pathology applications.

Indexed as

Mice, TransgenicAnimalsDiabetic NephropathiesDisease Models, AnimalHumansImage Processing, Computer-AssistedKidneyKidney DiseasesKidney GlomerulusMiceAmyloidosisArtificial intelligenceDiabetic nephropathyEnd-user applicationFeature analysisHIVHypothesis generationMinimal change disease

Identifiers

PMID39080444
PMCPMC11289473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.